About: PrefHer: finally addressing the preferences of her, too     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The development of trastuzumab is an example of the successful implementation of targeted therapy. Despite the advent of other agents that target HER2, such as lapatinib, pertuzumab, or trastuzumab emtansine, trastuzumab remains the main treatment for HER2-positive breast cancer in the metastatic, adjuvant, and neoadjuvant settings.
  • The development of trastuzumab is an example of the successful implementation of targeted therapy. Despite the advent of other agents that target HER2, such as lapatinib, pertuzumab, or trastuzumab emtansine, trastuzumab remains the main treatment for HER2-positive breast cancer in the metastatic, adjuvant, and neoadjuvant settings. (en)
Title
  • PrefHer: finally addressing the preferences of her, too
  • PrefHer: finally addressing the preferences of her, too (en)
skos:prefLabel
  • PrefHer: finally addressing the preferences of her, too
  • PrefHer: finally addressing the preferences of her, too (en)
skos:notation
  • RIV/61989592:15110/13:33144187!RIV14-MSM-15110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...iv/cisloPeriodika
  • 10
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 98799
http://linked.open...ai/riv/idVysledku
  • RIV/61989592:15110/13:33144187
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • plus; trial; phase-3; trastuzumab; adjuvant chemotherapy; HER2-positive breast-cancer (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [363D4F2F2B79]
http://linked.open...i/riv/nazevZdroje
  • Lancet Oncology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 14
http://linked.open...iv/tvurceVysledku
  • Melichar, Bohuslav
http://linked.open...ain/vavai/riv/wos
  • 000323942500023
issn
  • 1470-2045
number of pages
http://bibframe.org/vocab/doi
  • 10.1016/S1470-2045(13)70389-9
http://localhost/t...ganizacniJednotka
  • 15110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 76 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software